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Abstract
The antifertility activity of organoantimony(III) complexes PhSb[RC(NC6H4S)CH2(NC6H4S)CR’] {R
R’ CH (R) and R R’= CF (R,)} derived from corresponding sterically hindered bifunctional
tetradentat-]igadds in the ma.[e rats.w determined. The administration of compounds R1 and Rz.at the dose
level of 20 mg/kg, b. wt. slgmficantly reduced the weights of testes and eplddymldes. Auxihary glands
showed a significant reduction after the treatment of compound R only. Treated animals showed a notable
depression of spermatogenesis. The preleptotene spermatocytes were decreased by 76.19 and 47.06; the
secondary spermatocytes by 87.4% and 54.8% and the step-19 spermatids by Z2.9 and 46.77% respectively,
following the compound R and R2 treatment. Reduced sperm count and motility resulted in 100% negative
fertility in both the treated groups. A significant fall in the content of various biochemical parameters of
reproductive tissues was observed afterR andP treatment in comparison to controls.
Introduction
A large number of antimony(Ill) compounds have been tested as bactericides[l] and fungicides[2].
The pharmacological activity of antimony compounds has developed ever since the advent of rational
chemotherapy [3,4]. A number of antimony compounds have been found most effective against various
diseases [5]. Phenothiazines and related compounds with the -SC6H4N- moiety are well known to affect the
hypothalamous pituitary gonadal axis and thus resulting in a delay in ovulation and menstruation in women
[6]. Such type of effects were also observed in rates and dogs [7,8]. The rate of implantation was lowered and
reduction in litter size have been reported by some phenothiazine derivatives [9,10]. The survey of the
literature revealed that no attention has been paid to the activity of these compounds on the reproductive
system of male rats. In the present investigation we are reporting the antifertility activity of
organoantimony(III) complexes of sterically hindered bifunctional tetradentate ligands on the male rats.
Material and Methods
The organoantimony(III) compounds Ph3Sb[RC(NC6H4S)CH(NC6H4S)CR’ where R R’= CH
(R) and R R’ CF (R2) were synthesised by the reaction of Ph3Sb with the corresponding ligand in 1:1
molar ratio in refluxing benzene. The structure of these compounds have been reported earlier [11]. The
organic precursors used for the preparation of these complexes have been synthesised by the condensation of
2-aminothiophenol with corresponding I$-diketones (RCOCH2COR).
Wistar rats, weighing 150-180g, obtained from Jamia Hamdard, Hamdard University, New Delhi,
were used. Animals were housed in steal cages and maintained under standard conditions (12h light/12 h dark
cycle; 25 + 3C; 35-60% relative humidity). Rat feed (Hindustan Lever Ltd.) and tap water were provided ad
libitum.
The route and regimen of treatment were as out lined in table I. On day 61 testes, epididymides,
seminal vesicles, ventral prostate, heart, liver and adrenal were removed. The total protein, glycogen and
sailic acid were measured [12-14]. Tissues were fixed in Bouin’s fluid. Paraffin sections were made and
stained with hematoxylin and eosin. The evaluation of cell population dynamics was based on the
calculations made for each cell type per cross tubular sections. Various cell componenets were quantitatively
analysed. The mating exposure tests ofR and 1 treated male groups were performed from day 55 to day 60.
The mated females were separated to note the implantation sites on day 16th of pregnancy through
leparotomy. The results were analysed using student "t" test.
Results and discussion
The administration ofR at the dose level of 20 mg kg b. wt. caused the significant reduction in the
body weights of treated rats. However, R did not cause any significant change in body weights. The weights
of testes (P < 0.001), epididymides (p < 0.001), seminal vesicle (p < 0.01) and ventral prostate (p < 0.001)
were reduced significantly following the R treatment. Whereas R treatment only reduced the weight of
testes and epididymides. The number of step-I 9 spermatids were decreased by 72.9 and 46.77% following R
and R administration, respectively. The population of preleptotene spermatocytes were decreased by 76.19
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and 47.06 in R and R treated rats. The secondary spermatocytes were decreased by 87.4% and 54.8%,
respectively (table-II).
Table-l. Effects ofRt and R2 on the body wt. and the organ weights.
Treatment. Body Weight(g) Organ Weight (mg/100 g b.wt.)
Testes Epididymides Seminal Ventral
Vesicle Prostate
Gr.1 240+/-i.4 1345+1.7 529.5+1 i.2 605.7-9.5 308.5+2.02
Gr.2 165"*+/-7 1031.53"**-45’" 293.61’*9.14 ’5’66.8*+7.0 123.82"*+’1i.01
Gr.3 218+10
ns 1065+88" 369"*+13.4 607:1:25
ns 336.72+14.0
ns
ns" non significant, All figures + SEM, Levels of significance" *P < 0.01, **P < 0.001
Gr.1 Rat receiving vehicle (olive oil 0.2 ml/day) i.p. for 60 days
Gr.2 Rat treated withR (20 mg/kg b.wt.) i.p. for 60 days
Gr.3 Rat treated with R2 (20 mg/kg b.wt.) i.p. for 60 days
Grll
Table-ll. Testi.cular cell population dynamics following R1 and R2 Treatment
Testieular cell counts (number / 10 cross section)
Sertoli
cell
2.81
+0.02
Spermatogonia
6.870.65
’2’127+/-0.1"* Gr.2 1.75
Percent +0.07** (-) 66.95
deviation
Gi.3 2.6 18-0.4"
Percent +0.15
ns (-)44.68
deviation
ns" non significant, All figures + S.E.M.,
Preleptotene
19.95+1.9
10.56:t:1.2"
(-)47.06
Pachytene
29.29+0,73
25.04+1.i*
(-)14.51
Sec.spermat
ocytes,
48.1+3.8
6.064-119’*
(-)54.8
Step-19
spermatids
29.8+2.8
8.0751.1"*
(-)72.9
i5.86+1’7"
(-)46.77
Levels of significance: *P < 0.01 Compared with Control, **P < 0.001 Compared with controls
As shown in table III the protein content of testes, epididymides and ventral prostate were reduced
significantly (p < 0.001) following R treatment at the dose level of 20 mg / kg b. wt. as compared with
control. R treatment bring about the reduction of protein contents of cauda epididymides, sailic acid contents
of the testes, epididymides and auxiliary glands (seminal vesicle and ventral prostate) were depleted in both
the treated groups. Glycogen contents of testes were decreased significantly (p < 0.001) in comparison with
controls. Fructose in seminal vesicle was also declined.
R as shown in table IV the R and R, treated rats showed significant (p < 0.001) reduction in the
sperm concentration of testes and epididymides. The motility of the cauda epididymal sperm was also
reduced significantly (p < 0.001). Both the treatments reduced the fertility ofmale rats by 100%.
Administration ofR and R, for 60 days to male rats brought about a significant loss in testes weights, which
is mostly related to the nubmer of spermatids and spermatozoa present in the tissue. The reduced testicular
weights also indicative of wide spread damage [15]. Low cauda epididymal sperm count, presence of non-
motile spermatozoa and significant reduction in epididymal weights imply that these compounds induced
infertility might be caused by several factors 16] including the oxidative phosphorylation uncoupling 17].
The reduction in sperm density and motility in cauda epididymides is of importance with regard to
fertilization [18]. Reduction in number of sertoli cells following R treatment adversely affects the cell cycle
kinetics and influence both spermatogonia and praleptotene spermatocytes [19]. Depletion in protein, sailic
acid contents of testes and epididymides and auxiliary glands and testicular glycogen and fructose in seminal
vesicle reflects the antispermatogenic effects of the R and R compounds. The results demonstrate that the
compound R is more potent than compound R2.
Spectral evidences for both the compounds suggest [11] the presence of a pentacoordinated
antimony(Ill) atom in the pseudo-octahedral complexes, the geometry of which is due to the presence of lone
pair of electrons is. Spectral evidences also suggest a distortion in the basal plane ofthe complexes.
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Table-Ill. Effect ofR1 and R2 Treatment on biochemical parameters of male rat.
Protein(mg/gm) Sialic acid (mg/gm) Glyco-
Gr.3
Testes
173.88
+/- 5.31
155.53’
+ 2.12
168.86
+2.5
Cauda Seminal
Epididy- Vesicle
mis
211.14 1’92.74
+1.13 2.94
148.87’* 182.2
3.85 5.13
153.3’* 191.09
+ 5.8 1.28
Ventral
Prostate
171.12
1.06
gen
(rag/g)
Testes Cauda Seminal Ventral Testes
Epidid- Vesicle Prostate
ymis
4.67 6.27 5.26 4.82 2.16
+ 0.01 + 0.05 0.04 0.02 + 0.4
3.57** 3.63** 3.39** 3.63** 1.48**
0.01 0.05 0.05 0.01 0.02
3.66** 3.66** 3.54** 3.66** 1.61’*
:-0.05 0.017 0.034 + 0.03 + 0.02
ns non significant, Values are mean + S.E. of six determinations,
Levels of significance" *P < 0.01, **P < 0.001
tose
(mg/g)
Seminal
Veside
4.66
+0.2
Ascorbic
acid
(mg/gm)
Adrenal
3.30
+0.2
Table-IV. Sperm motility, concentration and fertility after Rt and R2 treatment
Treatment Sperm motility Sperm density (million/ml)
(Cauda epididymes) Testes Cauda epididymides
Gr.1 68.02 + 2.78 4.66 + 0.59 44.21 + 2.3
Gr.2 9.78 + 2.64** 1.i5 + 0.4** 4.30 + 0.17**
Gr.3 33.89 + 4.0** 2.35 + 0.2* 8.42 + 1.6"*
Fertility (%)
100 (+ ve)
100 (-ve)
100 (-ve)
All figures + SEM, Levels ofsignficance *P < 0.01, **P < 0.001
Fig. Structure ofPhSb[RC(NC6H4S)CH2(NC6H4S)CR’
It is evident from the above disussion that the antifertility activity of the compound (R) is more than
the compound . It is a well known fact that the presence of halogen atom in the compound enhances its
antifertility activity[20,21]. But in the present study the hexafluoro derivative l was found to be less active
than the non-fluorirated derivative. It might be possible that compound R may have a positive effect on male
reproductive system. This may be verified by carrying out the toxicological effect of both the compounds.
The study is in progress and the results will be published in due course of time.
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